Next-generation RSV vaccines avoid flipping out

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Respiratory Syncytial Virus (RSV) is a major cause of respiratory illness in infants and the elderly.
• Current vaccine strategies aim to elicit protective immune responses against RSV.
• The F protein is a key target for RSV vaccines, existing in prefusion and postfusion conformations.

Purpose of the Study:

• To compare the immunogenicity of RSV prefusion F protein versus postfusion F protein in clinical trials.
• To evaluate the induction of neutralizing antibodies and memory B cell activation by different F protein forms.

Main Methods:

• Clinical trials were conducted to assess immune responses.
• Levels of neutralizing antibodies were measured.
• The activation of memory B cells was analyzed.

Main Results:

• Prefusion F protein induced significantly higher levels of neutralizing antibodies compared to postfusion F protein.
• Prefusion F protein led to greater activation of memory B cells.

Conclusions:

• The prefusion conformation of the RSV F protein is a more potent immunogen than the postfusion conformation.
• These findings support the development of vaccines based on the prefusion F protein for enhanced efficacy against RSV.